FDA to use enforcement discretion on whole-grains health claims

The FDA says there is limited evidence to support health claims that whole-grain consumption can reduce diabetes risk, and that it will use its enforcement discretion for two food-label claims that whole grains may reduce the risk of type 2 diabetes. Food manufacturers are permitted to make the claims if they are worded in a manner that does not mislead consumers.

View Full Article in:

FoodBusinessNews.net (free registration) · CandyAndSnackToday.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC